The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,453,070 in first-year total cost, median $215,014.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BCMB-G (50)]5
- Special Emphasis Panel[ZRG1 BCMB-W (50)]1
Most frequent institutions
- NORTHEASTERN UNIVERSITY1
- NORTHWESTERN UNIVERSITY AT CHICAGO1
- ST. LOUIS COLLEGE OF PHARMACY1
- TORREY PINES INST FOR MOLECULAR STUDIES1
- UNIVERSITY OF NEBRASKA MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Design and Synthesis of Collybolide Probes for Kappa-Opioid Receptor1R21DA044430-01A1 | SHARMA, INDRAJEET | UNIVERSITY OF OKLAHOMA, OK | $136,804 | ZRG1 |
| 2018 | Synthesis and in vitro and in vivo screening of fused and tethered heterocyclic peptidomimetics for the discovery of new analgesics with decreased side effects1R21DA044425-01A1 | DOOLEY, COLETTEMCLAUGHLIN, JAY P.NEFZI, ADEL | TORREY PINES INST FOR MOLECULAR STUDIES, FL | $376,000 | ZRG1 |
| 2018 | Pharmacological Probes based on mitragynine pseudoindoxyl1R21DA045884-01 | MAJUMDAR, SUSRUTASAMES, DALIBOR | ST. LOUIS COLLEGE OF PHARMACY, MO | $216,230 | ZRG1 |
| 2018 | Photoactivatable ligands for nicotinic optopharmacology1R21DA044460-01A1 | DRENAN, RYAN MICHAEL | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $213,798 | ZRG1 |
| 2018 | Antidotes for Acute Cannabinoid Intoxication1R21DA045882-01 | VEMURI, KIRAN | NORTHEASTERN UNIVERSITY, MA | $185,233 | ZRG1 |
| 2017 | Optimization of MrgX1 allosteric agonists as potential therapies for chronic pain1R21DA045303-01 | HOPKINS, COREY R. | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $325,005 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.